The Japanese Biochemical Society/The Molecular Biology Society of Japan

[2P-0848] Transcriptomic alterations involving PRC2 at the embryonic stage govern tumorigenesis and clinical outcome in MYCN-driven neuroblastoma

〇Shoma Tsubota1, Satoshi Kishida1, Teppei Shimamura2, Miki Ohira3, Satoshi Yamashita4, Dongliang Cao1, Shinichi Kiyonari1, Toshikazu Ushijima4, Kenji Kadomatsu1 (1.Dept. of Mol. Biol., Nagoya Univ. Grad. Sch. of Med., 2.Div. of Systems. Biol., Nagoya Univ. Grad. Sch. of Med., 3.Res. Inst. Clin. Oncol., Saitama Cancer Center, 4.Div. of Epigenomics, Natl. Cancer Ctr. Res. Inst.)

Neuroblastoma、MYCN、PRC2

This archive has moved to the member page of The Molecular Biology Society of Japan and The Japanese Biochemical Society.
Members of the either society can access the abstracts via links at the member page of the sites.
Please feel free to contact the journal offices for any inquiries.

Password